Journal of Nutrition and Metabolism / 2017 / Article / Tab 2

Clinical Study

Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods

Table 2

Daily macronutrient intake profiles in combination with AA-MF and GMP-MF1.

Median and percentile nutrient intakes
AA-MFGMP-MF
10thMedian90th10thMedian90th

kcal1471207627111523214831520.33
 kcal/kg2329432130460.33
 kcal from MF16239391334069410070.002
 kcal from NF96915972247905153224670.53
g protein617610756811090.81
 g protein/kg0.851.101.500.801.101.701.00
 g PE from MF3359753053730.98
 g PE from MF/kg0.470.781.100.450.761.030.94
 % PE from MF34%77%84%40%71%86%0.58
 g protein from NF1220461122580.88
mg Phe4879241973544101425920.25
 mg Phe from MF00050851370.0001
 mg Phe from NF487924197341992925240.97
g carbohydrate2032944061953474730.10
 g carbohydrate from MF13612542911660.0001
 g carbohydrate from NF1502373631272403690.52
g sugar/d67122243781292270.69
 g sugar from MF03610222531090.10
 % energy from MF from sugar0%34%51%20%30%55%0.18
 g sugar from NF198917035691530.94
g fiber101739918280.93
 g fiber from MF00170240.67
 g fiber from NF101524916280.64
g fat37649235651020.62
 g fat from MF0120015260.0004
 g fat from NF3158822353930.63
g saturated fat815261021310.046
 g saturated fat from MF00104110.005
 g saturated fat from NF81525513280.85
g trans fat20.10.41.30.030.41.80.66
mg cholesterol29301184401360.76

1Nutrient intakes were based on 3-day food records (n = 30). Statistical analysis included ANOVA with effects for treatment, genotype, and treatment-genotype interaction. The values in this table represent the treatment comparison; 2AA-MF and GMP-MF did not contain trans fat nor cholesterol; Kruskal–Wallis test was used when data were skewed; AA-MF, amino acid medical food; GMP-MF, glycomacropeptide medical food; MF, medical food; NF, natural food; PE, protein equivalent.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.